BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9878203)

  • 1. Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease.
    Langston JW; Sastry S; Chan P; Forno LS; Bolin LM; Di Monte DA
    Exp Neurol; 1998 Dec; 154(2):684-90. PubMed ID: 9878203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low frequency of alpha-synuclein mutations in familial Parkinson's disease.
    Farrer M; Wavrant-De Vrieze F; Crook R; Boles L; Perez-Tur J; Hardy J; Johnson WG; Steele J; Maraganore D; Gwinn K; Lynch T
    Ann Neurol; 1998 Mar; 43(3):394-7. PubMed ID: 9506559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-Synuclein gene and Parkinson's disease. The French Parkinson's Disease Study Group.
    Science; 1998 Feb; 279(5354):1116-7. PubMed ID: 9508681
    [No Abstract]   [Full Text] [Related]  

  • 4. Cortical Lewy bodies in Alzheimer's disease.
    Kazee AM; Han LY
    Arch Pathol Lab Med; 1995 May; 119(5):448-53. PubMed ID: 7748074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation in the alpha-synuclein gene and sporadic Parkinson's disease, Alzheimer's disease, and dementia with lewy bodies.
    Higuchi S; Arai H; Matsushita S; Matsui T; Kimpara T; Takeda A; Shirakura K
    Exp Neurol; 1998 Sep; 153(1):164-6. PubMed ID: 9743579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases.
    Joachim CL; Morris JH; Selkoe DJ
    Ann Neurol; 1988 Jul; 24(1):50-6. PubMed ID: 3415200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.
    Krüger R; Kuhn W; Müller T; Woitalla D; Graeber M; Kösel S; Przuntek H; Epplen JT; Schöls L; Riess O
    Nat Genet; 1998 Feb; 18(2):106-8. PubMed ID: 9462735
    [No Abstract]   [Full Text] [Related]  

  • 8. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.
    Lippa CF; Fujiwara H; Mann DM; Giasson B; Baba M; Schmidt ML; Nee LE; O'Connell B; Pollen DA; St George-Hyslop P; Ghetti B; Nochlin D; Bird TD; Cairns NJ; Lee VM; Iwatsubo T; Trojanowski JQ
    Am J Pathol; 1998 Nov; 153(5):1365-70. PubMed ID: 9811326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of mutations in the coding region of the alpha-synuclein gene in pathologically proven Parkinson's disease.
    Chan P; Jiang X; Forno LS; Di Monte DA; Tanner CM; Langston JW
    Neurology; 1998 Apr; 50(4):1136-7. PubMed ID: 9566408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of the mitochondrial A7237T mutation in Parkinson's disease.
    Lücking CB; Kösel S; Mehraein P; Graeber MB
    Biochem Biophys Res Commun; 1995 Jun; 211(2):700-4. PubMed ID: 7794285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. III. The basal forebrain compared with other subcortical areas.
    Arendt T; Brückner MK; Bigl V; Marcova L
    J Comp Neurol; 1995 Jan; 351(2):223-46. PubMed ID: 7699112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autosomal dominant Lewy body parkinsonism in a four-generation family.
    Waters CH; Miller CA
    Ann Neurol; 1994 Jan; 35(1):59-64. PubMed ID: 8285594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to find the alpha-synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's disease.
    Chan P; Tanner CM; Jiang X; Langston JW
    Neurology; 1998 Feb; 50(2):513-4. PubMed ID: 9484385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha-Synuclein--a link between Parkinson and Alzheimer diseases?
    Heintz N; Zoghbi H
    Nat Genet; 1997 Aug; 16(4):325-7. PubMed ID: 9241262
    [No Abstract]   [Full Text] [Related]  

  • 15. Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteins.
    Vermersch P; Delacourte A; Javoy-Agid F; Hauw JJ; Agid Y
    Ann Neurol; 1993 May; 33(5):445-50. PubMed ID: 8498822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical genetic analysis of Parkinson's disease in the Contursi kindred.
    Golbe LI; Di Iorio G; Sanges G; Lazzarini AM; La Sala S; Bonavita V; Duvoisin RC
    Ann Neurol; 1996 Nov; 40(5):767-75. PubMed ID: 8957018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The native form of alpha-synuclein is not found in the cerebrospinal fluid of patients with Parkinson's disease or normal controls.
    Jakowec MW; Petzinger GM; Sastry S; Donaldson DM; McCormack A; Langston JW
    Neurosci Lett; 1998 Aug; 253(1):13-6. PubMed ID: 9754793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the alpha-synuclein gene mutation in patients with sporadic Parkinson's disease in the United Kingdom.
    Warner TT; Schapira AH
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):378-9. PubMed ID: 9728955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation.
    Jensen PH; Nielsen MS; Jakes R; Dotti CG; Goedert M
    J Biol Chem; 1998 Oct; 273(41):26292-4. PubMed ID: 9756856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathology in mice expressing human alpha-synuclein.
    van der Putten H; Wiederhold KH; Probst A; Barbieri S; Mistl C; Danner S; Kauffmann S; Hofele K; Spooren WP; Ruegg MA; Lin S; Caroni P; Sommer B; Tolnay M; Bilbe G
    J Neurosci; 2000 Aug; 20(16):6021-9. PubMed ID: 10934251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.